Recon: J&J touts ‘pretzel’ drug-device combo results for bladder cancer; FDA hands Zydus another Form 483 over facility deficiencies
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States